Dose-response relationship for breast cancer induction at radiotherapy dose

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Schneider, Uwe ^a,b   Sumila, Marcin ^b   Robotka, Judith ^b   Gruber, Günther ^b   Mack, Andreas ^b   Besserer, Jürgen ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Hirslanden Hospital   (Switzerland)

Author keywords

Breast cancer; Carcinogenesis; second cancer

Indexed keywords

ADULT; AGED; ARTICLE; ATOMIC BOMB SURVIVOR; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RISK; CARCINOGENESIS; DOSE RESPONSE; FEMALE; HODGKIN DISEASE; HUMAN; MANTLE FIELD RADIOTHERAPY; MEDIASTINUM; PREDICTION; RADIATION DOSE; RADIATION DOSE FRACTIONATION; TREATMENT PLANNING; ALGORITHM; ATOMIC WARFARE; BREAST; BREAST TUMOR; CASE CONTROL STUDY; COHORT ANALYSIS; MIDDLE AGED; RADIATION EXPOSURE; RADIATION INDUCED NEOPLASM; RADIATION RESPONSE; RADIOTHERAPY; RISK; STATISTICAL ANALYSIS;

ADULT; AGED; ALGORITHMS; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HODGKIN DISEASE; HUMANS; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WARFARE; RADIOTHERAPY; RISK;

EID: 79958033220     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-67     Document Type: Article

References (19)

1. Schneider U, Zwahlen D, Ross D, et al. Estimation of radiation-induced cancer from three-dimensional dose distributions: Concept of organ equivalent dose. Int J Radiat Oncol Biol Phys 2005, 61(5):1510-5. 10.1016/j.ijrobp.2004.12.040, 15817357.
2. Sachs RK, Brenner DJ. Solid tumor risks after high doses of ionizing radiation. Proc Natl Acad Sci USA 2005, 102(37):13040-5. 13, 10.1073/pnas.0506648102, 1199000, 16150705.
3. Schneider U, Stipper A, Besserer J. Dose-response relationship for lung cancer induction at radiotherapy dose. Z Med Phys 2010, 20(3):206-14.
4. Dörr W, Herrmann T. Second primary tumors after radiotherapy for malignancies. Treatment-related parameters. Strahlenther Onkol 2002, 178(7):357-62. 10.1007/s00066-002-0951-6, 12163989.
5. Travis LB, Gospodarowicz M, Curtis RE, et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 2002, 94(3):182-92.
6. Gilbert ES, Stovall M, Gospodarowicz M, et al. Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res 2003, 159(2):161-73. 10.1667/0033-7587(2003)159[0161:LCATFH]2.0.CO;2, 12537521.
7. Diallo I, Haddy N, Adjadj E, et al. Frequency distribution of second solid cancer locations in relation to the irradiated volume among 115 patients treated for childhood cancer. Int J Radiat Oncol Biol Phys 2009, 74(3):876-83. 10.1016/j.ijrobp.2009.01.040, 19386434.
8. Travis LB, Hill DA, Dores GM, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 2003, 290(4):465-75. 10.1001/jama.290.4.465, 12876089.
9. van Leeuwen FE, Klokman WJ, Stovall M, et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 2003, 95(13):971-80. 10.1093/jnci/95.13.971, 12837833.
10. Inskip PD, Robison LL, Stovall M, Smith SA, Hammond S, Mertens AC, Whitton JA, Diller L, Kenney L, Donaldson SS, Meadows AT, Neglia JP. Radiation dose and breast cancer risk in the childhood cancer survivor study. J Clin Oncol 2009, 27(24):3901-7. 10.1200/JCO.2008.20.7738, 2734395, 19620485.
11. Preston DL, Ron E, Tokuoka S, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 2007, 168(1):1-64. 10.1667/RR0763.1, 17722996.
12. Schneider U. Mechanistic model of radiation-induced cancer after fractionated radiotherapy using the linear-quadratic formula. Med Phys 2009, 36(4):1138-43. 10.1118/1.3089792, 19472619.
13. Hoppe RT. Radiation therapy in the management of Hodgkin's disease. Semin Oncol 1990, 17(6):704-15.
14. Hancock SL, Hoppe RT. Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease. Semin Radiat Oncol 1996, 6(3):225-242. 10.1016/S1053-4296(96)80018-X, 10717180.
15. Swerdlow AJ, Barber JA, Hudson GV, et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 2000, 18(3):498-509.
16. Dores GM, Metayer C, Curtis RE, et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 2002, 20(16):3484-94. 10.1200/JCO.2002.09.038, 12177110.
17. van Leeuwen FE, Klokman WJ, Veer MB, et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 2000, 18(3):487-97.
18. De Bruin ML, Sparidans J, van't Veer MB, et al. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes. J Clin Oncol 2009, 27(26):4239-46. 10, 10.1200/JCO.2008.19.9174, 19667275.
19. Koh ES, Tran TH, Heydarian M, Sachs RK, Tsang RW, Brenner DJ, Pintilie M, Xu T, Chung J, Paul N, Hodgson DC. A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk. Radiat Oncol 2007, 2:13. 10.1186/1748-717X-2-13, 1847517, 17362522.